| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.05. | Leap Therapeutics Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| 13.05. | LEAP THERAPEUTICS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.05. | Leap Therapeutics, Inc.: Leap Therapeutics Reports First Quarter 2024 Financial Results | 574 | PR Newswire | CAMBRIDGE, Mass., May 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial... ► Artikel lesen | |
| 13.05. | LEAP THERAPEUTICS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.04. | Leap Therapeutics To Sell $40 Mln Of Shares In Private Placement; Stock Up Over 14% | 7 | RTTNews | ||
| 11.04. | Leap Therapeutics announces $40 million private placement | 2 | Seeking Alpha | ||
| 11.04. | LEAP THERAPEUTICS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.03. | Leap Therapeutics: Q4 Earnings Insights | 2 | Benzinga.com | ||
| 18.03. | Leap Therapeutics files for $200M mixed shelf offering | 2 | Seeking Alpha | ||
| 18.03. | Leap Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 5 | Reuters | ||
| 18.03. | Leap Therapeutics GAAP EPS of -$0.46 beats by $0.10 | 3 | Seeking Alpha | ||
| 18.03. | LEAP THERAPEUTICS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.03. | Leap Therapeutics, Inc.: Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results | 142 | PR Newswire | CAMBRIDGE, Mass., March 18, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial... ► Artikel lesen | |
| 18.03. | LEAP THERAPEUTICS, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 23.01. | LEAP THERAPEUTICS, INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 17.01. | Leap Therapeutics rises as cancer therapy shows promise in mid-stage study | 9 | Reuters | ||
| 16.01. | LEAP THERAPEUTICS, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 02.01. | Leap Therapeutics, Inc.: Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients | 152 | PR Newswire | CAMBRIDGE, Mass., Jan. 2, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 812 |
| RHEINMETALL | 488 |
| TUI | 476 |
| GAMESTOP | 456 |
| EVOTEC | 364 |
| DEUTSCHE LUFTHANSA | 359 |
| NEL | 337 |
| BAYER | 291 |
| SNOWFLAKE | 288 |
| TESLA | 275 |
| BYD | 258 |
| BASF | 207 |
| VOLKSWAGEN | 197 |
| PORSCHE SE | 182 |
| DEUTSCHE TELEKOM | 180 |
| APPLE | 177 |
| MERCEDES-BENZ | 162 |
| THYSSENKRUPP | 158 |
| ALLIANZ | 149 |
| DEUTSCHE BANK | 138 |
| COMMERZBANK | 132 |
| PLUG POWER | 131 |
| BROADCOM | 130 |
| MICROSOFT | 124 |
| RWE | 123 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
